Gelesis investor relations
WebAug 15, 2024 · Gelesis management will host a conference call today at 8:30 am ET to discuss the second quarter 2024 results, followed by a question-and-answer period. The … WebInvestor Relations. Genesis Healthcare, Inc. (OTC Expert Market: GENN) is a holding company with subsidiaries that, on a combined basis, comprise one of the nation's …
Gelesis investor relations
Did you know?
WebMar 17, 2024 · Investor Relations: ICR Lynne Collier [email protected] 646-430-2216 Media Relations: Katie Sullivan [email protected] WebAcquisition (Non Open Market) Direct. 483,219. 483,219. 1. 2. Back to GLSH Overview. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and ...
WebMay 12, 2024 · Investors are encouraged to review the related GAAP financial measure and the reconciliation of this non-GAAP financial measure to its most directly comparable GAAP financial measure, and not to rely on any single financial measure to evaluate our business. Contact. Media & Investor Relations. Katie Sullivan [email protected]
WebApr 10, 2024 · Investor Relations Business Wire NYSE to Suspend Trading Immediately in Gelesis Holdings, Inc. (GLS) and Commence Delisting Proceedings Provided by Business Wire. Apr 10, 2024 8:24 PM UTC ... WebMay 9, 2024 · Gelesis management will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. Conference Call Details Date: Thursday, May 12, 2024 Time: 4:30 p.m....
WebJul 19, 2024 · Gelesis and Capstar will host a joint investor conference call to discuss the transaction today, July 19, 2024, at 8:30 a.m. Eastern Time. A telephone replay of the …
WebInvestor Relations, Gelesis Holdings, Inc. Ms. Lynne Collier is a Head of Consumer Discretionary at Water Tower Research LLC and an Independent Director at FAT Brands, Inc. She is on the Board of ... top firming creamsWebAug 4, 2024 · BOSTON-- ( BUSINESS WIRE )-- Gelesis Holdings, Inc. (NYSE:GLS) (“Gelesis” or the “Company”), the maker of Plenity® for weight management, today announced that the Company will report financial... picture of five week fetusWebAug 15, 2024 · Gelesis management will host a conference call today at 8:30 am ET to discuss the second quarter 2024 results, followed by a question-and-answer period. The live call can be accessed via webcast... picture of flagellateWebApr 5, 2024 · Investor Relations Gelesis Holdings Inc GLS Stock Quote ... Gelesis Holdings Inc is a biotherapeutics company advancing a novel category of treatments for weight management and gut related chronic ... top firming cream for faceWebNov 21, 2024 · Gelesis, Inc. Investor Relations 0.16 +0.00 ( 0.86% ) Vol: 67,626 Investor Relations We are a biotherapeutics company built for consumer engagement. We aim to … At Gelesis, we promise to treat your data with respect and will not share your … Archived Events & Presentations. 03/13/2024. Investor Presentation. … picture of fish under the oceanWebMar 24, 2024 · Gelesis provides guidance based on current market conditions and expectations for revenue, gross profit, and Adjusted EBITDA, which is a non-GAAP financial measure. Gelesis estimates product revenue, net, of about $58 million in 2024. Gelesis estimates a gross profit of $25 million to $30 million. picture of flagletsWebJan 14, 2024 · BOSTON, MA & AUSTIN, TX, January 13, 2024 – Gelesis, the maker of Plenity ®, an FDA-cleared weight management approach, announced today the completion of its business combination with Capstar... picture of fjords in norway